C. Mattler

A controlled, double-blind investigation of the clozapine discontinuation syndrome with conversion to either olanzapine or placebo

G. Tollefson, B. Kinon, M. Dellva, 1998, European Neuropsychopharmacology.

Controlled, Double-blind Investigation of the Clozapine Discontinuation Symptoms With Conversion to Either Olanzapine or Placebo

J. Kane, G. Tollefson, B. Kinon, 1999 .

Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo. The Collaborative Crossover Study Group.

J. Kane, G. Tollefson, B. Kinon, 1999, Journal of clinical psychopharmacology.

Novel non-viral vectors for gene delivery: synthesis of a second-generation library of mono-functionalized poly-(guanidinium)amines and their introduction into cationic lipids.

D. Scherman, G. Byk, M. Frederic, 1998, Biotechnology and bioengineering.

Fibrinolytic Activity Comparison of Commercially Available Streptokinase, Urokinase, and Tissue Plasminogen Activator

L. Mattler, C. Mattler, R. Holden, 1992 .